Advances in the surgical treatment of esophageal cancer since 1965
Advances in the surgical treatment of esophageal cancer since 1965
复制标题
1965年以来食管癌外科治疗进展
DOI：
10.1002/ags3.12332
复制
发表时间：
2020
影响因子：
2.7
通讯作者：
H. Matsubara
中科院分区：
文献类型：
--
作者：
H. Matsubara
在日本，自1965年由中山幸美、胜茂嗣和赤仓一郎医生成立日本食管疾病学会以来，食管癌的治疗经历了重大发展。当学会成立时，手术是食管癌的一线治疗方法。从那时起，该协会一直由三位连续的主席-博士加藤，中山和佐藤。在此期间，由于手术技术的快速改进，手术相关死亡率下降至5%-6%。从1980年开始，双侧颈淋巴结清扫技术受到关注，并逐渐报道了良好的长期结局。1990年，该协会进行的一项全国性问卷调查显示，采用三野淋巴结清扫技术比采用两野淋巴结清扫技术获得了更有利的长期结局。从那时起，三野淋巴结清扫技术已被公认并广泛用作治疗食管癌的标准外科手术。在临床研究检查了各种术前和术后持续治疗在改善结局方面的效用后，术前化疗被认为是治疗指南中的标准治疗。此外，还开发了微创手术方法，包括内窥镜和机器人辅助手术，目前已在全科实践中应用。然而，不可切除和复发性食管癌仍然难以治疗，应开发其他治疗方法。
In Japan, the treatment of esophageal cancer has undergone significant development since the Japanese Society for Esophageal Diseases was established in 1965 by Doctors Komei Nakayama, Shigetsugu Katsura, and Ichiro Akakura. When the Society was established, surgery was the first‐line treatment for esophageal cancer. Since then, the Society has been led by three successive chairpersons—Doctors Katsura, Nakayama, and Satoh. Over this time, surgery‐related mortalities declined to 5%‐6% because of the rapid improvements in surgical technique. Beginning in 1980, the bilateral cervical lymph node dissection technique gained attention, and favorable long‐term outcomes were gradually reported. A nationwide questionnaire survey, conducted by the Society in 1990, showed that more favorable long‐term outcomes were achieved by following the three‐field lymph node dissection technique than by following the two‐field lymph node dissection technique. Since then, the three‐field lymph node dissection technique has been recognized and widely used as the standard surgical procedure for treating esophageal cancer. After clinical studies examined the utility of various pre‐ and postoperative adjunctive therapies in outcome improvements, preoperative chemotherapy was recognized as the standard treatment in the therapy guidelines. Additionally, less invasive surgical methods have been developed, including endoscopic and robot‐assisted surgeries, which are applied in general practice now. However, unresectable and recurrent esophageal cancers remain difficult to treat, and additional treatments should be developed.
日本食管癌的分类，第11版：第一部分。
DOI：
10.1007/s10388-016-0551-7
发表时间：
2017
期刊：
Esophagus : official journal of the Japan Esophageal Society
影响因子：
--
作者：
Japan Esophageal Society
通讯作者：
Japan Esophageal Society